TuHURA Biosciences, Inc.
HURA
We are a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. Our proprietary Immune FxTM technology platform, or IFx, is an innate immune agonist technology designed to trick the body's immune system to attack tumor cells by making…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (FY)
$0.00
Net Income (TTM)
-$30M
▼ -38.6% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF (TTM)
-$24M
▼ -87.4% YoY
Op. Cash Flow (TTM)
-$24M
▼ -87.6% YoY
Net Debt
$8M
Cash & Equiv.
$2M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with HURA
Held by ETFs
HURA is in 1 US ETF. The largest of them, with HURA's weight in each:
TuHURA Biosciences (HURA) in three numbers
Questions about TuHURA Biosciences
Is TuHURA Biosciences a high-quality business?
TuHURA Biosciences scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is share count change at 28840662.3%. The Quality tab shows every check against its target.
Does TuHURA Biosciences (HURA) pay a dividend?
No. TuHURA Biosciences (HURA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 10 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in HURA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing HURA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.